Showing 14,121 - 14,140 results of 46,043 for search '(( 50 ((a decrease) OR (nn decrease)) ) OR ( 5 ((step decrease) OR (mean decrease)) ))', query time: 0.81s Refine Results
  1. 14121

    The Effect of Catheter Ablation on Left Atrial Size and Function for Patients with Atrial Fibrillation: An Updated Meta-Analysis by Bin Xiong (445687)

    Published 2015
    “…Total and subgroup analyses were implemented using Cochrane Review Manager Version 5.2. Weighted mean differences with 95% confidence intervals were used to express the results of continuous outcomes using fixed or random effect models. …”
  2. 14122
  3. 14123
  4. 14124

    <b>LINEAR PROGRAMMED DIETARY PLAN DATASET </b><b>ON IMPROVING ENERGY INTAKE AMONG CHILDREN LIVING WITH HIV AGED 2-5 YEARS</b>a by Harriet Carin (17951636)

    Published 2024
    “…</p><p dir="ltr">There was a significant increase in mean knowledge change (mean change) =2.48(95%CI=1.5-3.3), P=<0.01) as a result of an intervention (F=5.1; P=0.025) with an effect size of (Cohen’s d=0.5{95%CI=0.21-0.78}.The mean change for attitude was 8.49{95%CI=7.02-9.96}, P=<0.001 with significant strength of the intervention F=48.9; P=0.001) with effect size (Cohen’s d =1.2{95%CI=0.87-1.48}.The mean change for energy intake was 351.82(95%CI =303.20-400.44}, P=<0.001) with significant strength of the intervention F=57.95; P=0.001) and effect size (Cohen’s d=1.5(1.29-1.73)</p><p dir="ltr">The intervention effectively increased knowledge and changed attitudes, increasing energy intake among this population.…”
  5. 14125

    Data_Sheet_1_Forced changes in El Niño–Southern Oscillation due to global warming and the associated uncertainties in ACCESS-ESM1.5 large ensembles.docx by Harun A. Rashid (13258725)

    Published 2022
    “…There is a modest but statistically significant GW-induced increase in the ensemble-mean ENSO amplitude and a sizable ensemble variation (due to internal variability) with both increases (in 80% of the members) and decreases. …”
  6. 14126
  7. 14127

    Table_1_Five-Year Outcomes of Patients With Mitral Structural Valve Deterioration Treated With Transcatheter Valve in Valve Implantation – A Single Center Prospective Registry.DOCX... by Nili Schamroth Pravda (11411216)

    Published 2022
    “…Our cohort consisted of 49 patients (mean age 77.4 ± 10.5 years, 65.3% female). The indications for TM-ViV were mainly for regurgitant pathology (77.6%). …”
  8. 14128

    Image_3_Five-Year Outcomes of Patients With Mitral Structural Valve Deterioration Treated With Transcatheter Valve in Valve Implantation – A Single Center Prospective Registry.JPEG... by Nili Schamroth Pravda (11411216)

    Published 2022
    “…Our cohort consisted of 49 patients (mean age 77.4 ± 10.5 years, 65.3% female). The indications for TM-ViV were mainly for regurgitant pathology (77.6%). …”
  9. 14129

    Image_1_Five-Year Outcomes of Patients With Mitral Structural Valve Deterioration Treated With Transcatheter Valve in Valve Implantation – A Single Center Prospective Registry.JPEG... by Nili Schamroth Pravda (11411216)

    Published 2022
    “…Our cohort consisted of 49 patients (mean age 77.4 ± 10.5 years, 65.3% female). The indications for TM-ViV were mainly for regurgitant pathology (77.6%). …”
  10. 14130

    Image_2_Five-Year Outcomes of Patients With Mitral Structural Valve Deterioration Treated With Transcatheter Valve in Valve Implantation – A Single Center Prospective Registry.JPEG... by Nili Schamroth Pravda (11411216)

    Published 2022
    “…Our cohort consisted of 49 patients (mean age 77.4 ± 10.5 years, 65.3% female). The indications for TM-ViV were mainly for regurgitant pathology (77.6%). …”
  11. 14131
  12. 14132
  13. 14133

    Data_Sheet_1_CA1 Neurons Acquire Rett Syndrome Phenotype After Brief Activation of Glutamatergic Receptors: Specific Role of mGluR1/5.docx by Saju Balakrishnan (58265)

    Published 2018
    “…We examined the role of mGluR1/5 in more detail. The effects of the agonist (S)-3,5-dihydroxyphenylglycine (DHPG) were the same as AMPA and NMDA and occluded by mGluR1/5 antagonists. …”
  14. 14134

    <b>L-Tryptophan as a Frontier in Diabetes Management: A Pilot Study</b> by dr.gayathri M rao (22045067)

    Published 2025
    “…On 11th day after sacrifice, Intestinal absorption of glucose, Pancreatic and intestinal Na+-K+ ATPase (NKA) activity, intestinal Nitric Oxide (NO), Blood & pancreatic Glucagon like peptide-1(GLP-1), serum total protein, urea and cholesterol, liver and pancreatic histology were studied.</p><p dir="ltr">A significant decrease in the glucose absorption and blood glucose level in the tryptophan treated diabetic group in comparison with diabetic controls. …”
  15. 14135
  16. 14136
  17. 14137
  18. 14138
  19. 14139
  20. 14140